Natco Pharma Ltd.
BSE: 524816 | Sector: Health care |
NSE: NATCOPHARM | ISIN Code: INE987B01026 |
BSE 00:00 | 17 May | 719.10 |
18.75 (2.68%) |
OPEN
695.20 |
HIGH
730.20 |
LOW
695.00 |
NSE 00:00 | 17 May | 719.00 |
18.95 (2.71%) |
OPEN
694.00 |
HIGH
725.90 |
LOW
694.00 |
OPEN | 695.20 |
PREVIOUS CLOSE | 700.35 |
VOLUME | 10608 |
52-Week high | 1188.95 |
52-Week low | 645.45 |
P/E | 50.96 |
Mkt Cap.(Rs cr) | 13,127 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Natco Pharma Ltd.
Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company's focus is primarily on niche therapeutic areas and complex products. The company sells its products in over 40 countries. FDF products are sold in the United States I...> More
Natco Pharma Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
13,127 | |
EPS - TTM | (![]() |
[*S] | 14.11 |
P/E Ratio | (X) | [*S] | 50.96 |
Face Value | (![]() |
2 | |
Latest Dividend | (%) | 100.00 | |
Latest Dividend Date | 24 Feb 2022 | ||
Dividend Yield | (%) | 0.73 | |
Book Value / Share | (![]() |
[*S] | 229.69 |
P/B Ratio | (![]() |
[*S] | 3.13 |
News
Announcement
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
-
Compliance Certificate For The Quarter Ended 31St March 2022
-
Statement Of Investor Complaints For The Quarter Ended March 2022
-
Reg.40(10) PCS Certificate For The Year Ended 31St March 2022
Natco Pharma Ltd - Financial Results
Particulars (![]() |
Dec 2021 | Dec 2020 | % Chg |
Net Sales | 560.5 | 355.2 | 57.8 |
Other Income | 30.2 | 30.8 | -1.95 |
Total Income | 590.7 | 386 | 53.03 |
Total Expenses | 458.7 | 272.7 | 68.21 |
Operating Profit | 132 | 113.3 | 16.5 |
Net Profit | 80.4 | 63.4 | 26.81 |
Equity Capital | 36.5 | 36.4 | - |
Natco Pharma Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Alembic Pharma | 747.60 | 1.04 | 14694.08 |
Ajanta Pharma | 1706.40 | 1.35 | 14572.66 |
Suven Pharma | 516.30 | 1.71 | 13145.00 |
Natco Pharma | 719.10 | 2.68 | 13127.17 |
J B Chem & Pharm | 1617.60 | -0.18 | 12504.05 |
Glenmark Pharma. | 402.25 | 2.48 | 11351.49 |
ERIS Lifescience | 697.55 | 1.27 | 9486.68 |
Natco Pharma Ltd - SHAREHOLDING PATTERN
|
|
Natco Pharma Ltd - Research Reports
Date | Broker | Action | Price | Report |
15/11/2021 | Nirmal Bang | Buy | 830 | ![]() |
Natco Pharma Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | 2.86% | 2.80% | -0.09% | 0.12% |
1 Month | -11.46% | -11.39% | -6.89% | -6.96% |
3 Month | -18.56% | -18.53% | -6.17% | -6.04% |
6 Month | -12.44% | -12.46% | -9.48% | -9.16% |
1 Year | -21.88% | -21.80% | 9.56% | 8.95% |
3 Year | 37.67% | 38.00% | 43.20% | 42.54% |
Natco Pharma Ltd - STOCK STRENGTH
Today's Low/High | 695.00 | 730.20 | |
Week Low/High | 645.45 | 740.00 | |
Month Low/High | 645.45 | 827.00 | |
YEAR Low/High | 645.45 | 1189.00 | |
All TIME Low/High | 1.60 | 1189.00 |
Quick Links for Natco Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices